Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature.
BRAF
Follicular thyroid carcinoma
Lymph node metastasis
NRAS
Papillary thyroid carcinoma
Prognosis
TERT
Journal
Thyroid research
ISSN: 1756-6614
Titre abrégé: Thyroid Res
Pays: England
ID NLM: 101469037
Informations de publication
Date de publication:
04 Feb 2022
04 Feb 2022
Historique:
received:
12
11
2021
accepted:
28
01
2022
entrez:
5
2
2022
pubmed:
6
2
2022
medline:
6
2
2022
Statut:
epublish
Résumé
Follicular thyroid carcinomas (FTCs) rarely metastasize to regional lymph nodes, and descriptions of synchronous lateral lymph node metastases of FTC and papillary thyroid carcinoma (PTC) are lacking. We describe a 43-year-old female with a preoperative cytology indicating a right-sided PTC with lateral lymph node metastases. She underwent a total thyroidectomy and central and lateral lymph node dissection, and histopathology confirmed a multifocal tall cell variant PTC together with a 12 mm minimally invasive FTC in the ipsilateral lobe. While the central compartment demonstrated metastatic PTC, the lateral compartment contained PTC metastases alongside a 15 mm large follicular-patterned mass in a separate lymph node. As the cells lacked PTC associated nuclear changes, the possibility of a lateral lymph node metastasis of FTC was considered, with the possibility of ectopic thyroid tissue as a differential diagnosis. By utilizing next-generation sequencing, a Q61R NRAS mutation was pinpointed, thus proving the tissue as tumorous. The patient underwent radioiodine treatment and is currently monitored following a negative whole-body scan. This is probably the first case report of a patient with co-existing lateral lymph node PTC and FTC metastases. Consulting previous publications, there is currently a gap of knowledge in terms of how patients with regional FTC metastases should be followed-up and treated, especially when co-occurring with spread high-risk PTC subtypes. Moreover, what guides a seemingly indolent FTC to spread via the lymphatic system remains to be defined from a molecular standpoint.
Sections du résumé
BACKGROUND
BACKGROUND
Follicular thyroid carcinomas (FTCs) rarely metastasize to regional lymph nodes, and descriptions of synchronous lateral lymph node metastases of FTC and papillary thyroid carcinoma (PTC) are lacking.
CASE PRESENTATION
METHODS
We describe a 43-year-old female with a preoperative cytology indicating a right-sided PTC with lateral lymph node metastases. She underwent a total thyroidectomy and central and lateral lymph node dissection, and histopathology confirmed a multifocal tall cell variant PTC together with a 12 mm minimally invasive FTC in the ipsilateral lobe. While the central compartment demonstrated metastatic PTC, the lateral compartment contained PTC metastases alongside a 15 mm large follicular-patterned mass in a separate lymph node. As the cells lacked PTC associated nuclear changes, the possibility of a lateral lymph node metastasis of FTC was considered, with the possibility of ectopic thyroid tissue as a differential diagnosis. By utilizing next-generation sequencing, a Q61R NRAS mutation was pinpointed, thus proving the tissue as tumorous. The patient underwent radioiodine treatment and is currently monitored following a negative whole-body scan.
CONCLUSIONS
CONCLUSIONS
This is probably the first case report of a patient with co-existing lateral lymph node PTC and FTC metastases. Consulting previous publications, there is currently a gap of knowledge in terms of how patients with regional FTC metastases should be followed-up and treated, especially when co-occurring with spread high-risk PTC subtypes. Moreover, what guides a seemingly indolent FTC to spread via the lymphatic system remains to be defined from a molecular standpoint.
Identifiants
pubmed: 35120551
doi: 10.1186/s13044-022-00120-w
pii: 10.1186/s13044-022-00120-w
pmc: PMC8815265
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1Subventions
Organisme : Cancerfonden
ID : Junior Clinical Investigator Award
Informations de copyright
© 2022. The Author(s).
Références
J Clin Endocrinol Metab. 2018 May 1;103(5):2009-2015
pubmed: 29474644
Adv Ther. 2021 Oct;38(10):5144-5164
pubmed: 34423400
Tumori. 2011 May-Jun;97(3):296-303
pubmed: 21789006
Histopathology. 2021 Oct;79(4):661-666
pubmed: 34008223
Endocr Pathol. 2018 Mar;29(1):9-14
pubmed: 28710706
Surgery. 2008 Dec;144(6):1070-7; discussion 1077-8
pubmed: 19041020
Endocr Relat Cancer. 2018 Jul;25(7):723-733
pubmed: 29692346
Head Neck. 2015 Oct;37(10):E125-9
pubmed: 25491252
J Mol Diagn. 2021 Feb;23(2):212-222
pubmed: 33197629
Am Surg. 2018 Sep 1;84(9):e348-e349
pubmed: 30454493
J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):227-30
pubmed: 25153225
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Oncogene. 2014 Oct 16;33(42):4978-84
pubmed: 24141777
Int J Mol Sci. 2021 Feb 09;22(4):
pubmed: 33572167
Thyroid. 2010 Dec;20(12):1341-9
pubmed: 21034228
Eur J Cancer. 2019 Feb;108:41-49
pubmed: 30648628
Mod Pathol. 2020 Jul;33(7):1264-1274
pubmed: 31937902
Diagn Pathol. 2019 Nov 20;14(1):130
pubmed: 31747942
Endocr Relat Cancer. 1999 Mar;6(1):109-15
pubmed: 10732793
Ann Diagn Pathol. 2020 Oct;48:151584
pubmed: 32871503